We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of SGMO yet.

SGMO Hedge Fund Activity: Q1 2026 in Review

112 of the 8,143 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2026, worth a combined $26M — down 0.48% from $26.2M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SGMO positions and 16 closed out — a net gain of 13 holders — while 30 added to existing stakes and 16 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $16.1M. The largest seller was Renaissance Technologies, cutting an estimated $1.83M.

  • 112 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2026, up from 105 in Q4 2025.
  • Funds reported $26M of SANGAMO THERAPEUTICS INC stock for Q1 2026, down 0.48% quarter-over-quarter.
  • 29 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2026 and 16 closed out, a net change of +13 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2026 was Armistice Capital, an estimated $16.1M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2026 was Renaissance Technologies, an estimated $1.83M sold.

Based on aggregated 13F filings for Q1 2026.